6 Meridian’s Amphastar Pharmaceuticals AMPH Stock Holding History

6 Meridian’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,838	Closed	-$420K	–	396
2021 Q2	$420K	Sell	20,838 -306	-1%	-$5.77K	0.03%	190
2021 Q1	$387K	Buy	+21,144	New	+$393K	0.03%	201

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

6 Meridian's AMPH Position: Q3 2021 in Review

6 Meridian sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2021, closing a stake of 20,838 shares — an estimated $420K sold.

6 Meridian first reported a position in AMPH in Q1 2021 and held it in 2 quarters. The position peaked at $420K in Q2 2021. 139 funds tracked by Wall St. Rank hold AMPH as of Q3 2021.

6 Meridian reported no remaining Amphastar Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
6 Meridian sold 20,838 Amphastar Pharmaceuticals shares in Q3 2021, an estimated $420K.
6 Meridian first reported a position in Amphastar Pharmaceuticals in Q1 2021 and held it in 2 quarters.
6 Meridian's Amphastar Pharmaceuticals position peaked at $420K in Q2 2021.
139 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.